SWITGLIM MP 2/15 (Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg))

Switglim MP 2 Tablet is an oral medication designed to help manage blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This formulation combines two active ingredients that work synergistically to enhance the body’s sensitivity to insulin and improve the utilization of glucose. The effectiveness of this medication is maximized when combined with a balanced diet and regular physical activity, contributing to better overall glycemic control. Patients are advised to follow the prescribed dosage and duration specified by their healthcare provider, typically taking the tablet during meal times to minimize gastrointestinal discomfort. In the event of a missed dose, it should be taken promptly unless it’s near the time for the subsequent dose; in such cases, the missed dose should be skipped to maintain the regular dosing schedule. It is important to avoid taking double doses, as this could lead to hypoglycemia, a condition characterized by abnormally low blood sugar levels. Individuals taking this medication should be vigilant for signs of hypoglycemia, particularly if it is used in conjunction with other diabetes medications, alcohol consumption, or missed meals. Regular monitoring of blood sugar levels is recommended. Additional side effects that may occur include gastrointestinal disturbances, headaches, and respiratory issues. Patients should disclose any pre-existing kidney, liver, or cardiovascular conditions to their physician prior to initiation of therapy.